Optilite C-Reactive Protein Kit - Product Usage: The Optilite C-Reactive Protein Reagent is inten...
FDA Device Recall #Z-0671-2020 — Class II — February 19, 2019
Recall Summary
| Recall Number | Z-0671-2020 |
| Classification | Class II — Moderate risk |
| Date Initiated | February 19, 2019 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | The Binding Site Group, Ltd. |
| Location | Birmingham, N/A |
| Product Type | Devices |
| Quantity | 10 kits |
Product Description
Optilite C-Reactive Protein Kit - Product Usage: The Optilite C-Reactive Protein Reagent is intended for the quantitative in vitro determination of C-reactive protein (CRP) concentration in serum using the Binding Site Optilite analyser. Measurement of C-Reactive Protein aids in evaluation of the amount of injury to body tissues and for evaluation of infection, tissue injury, and inflammatory disorders. This test should be used in conjunction with other laboratory and clinical findings. The Optilite C-Reactive Protein Calibrator is intended for the calibration of the Optilite C-Reactive Protein Reagent on the Optilite analyser. The Optilite C-Reactive Protein Controls are intended for use in quality control by monitoring accuracy and precision for the Optilite C-Reactive Protein Reagent.
Reason for Recall
Deterioration of C-reactive protein (CRP) reagent in Optilite C-Reactive Protein Kits
Distribution Pattern
US Nationwide distribution in the states of CA and GA. OUS not provided due to product being manufacture OUS
Lot / Code Information
Model Number: NK044.OPT.A Lot 437705 UDI 05051700018449 Medical Device Listing number D317086
Other Recalls from The Binding Site Group, Ltd.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0274-2022 | Class II | Freelite Human Lambda Free Kit (for use on the ... | Oct 15, 2021 |
| Z-2030-2021 | Class II | FREELITE Human Kappa Free Kit for use on the Ro... | May 20, 2021 |
| Z-0943-2021 | Class II | Optilite Freelite Mx Kappa Free Kit REF LK016.... | Nov 18, 2020 |
| Z-2071-2020 | Class II | The Optilite Clinical Chemistry Analyzer. IVD. ... | Apr 9, 2020 |
| Z-1500-2020 | Class II | Rheumatoid Factor (RF) Kit for use on SPAPLUS, ... | Nov 6, 2019 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.